KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Other Non-Current Liabilities (2016 - 2025)

Biogen has reported Other Non-Current Liabilities over the past 17 years, most recently at $748.5 million for Q4 2025.

  • Quarterly results put Other Non-Current Liabilities at $748.5 million for Q4 2025, up 2.21% from a year ago — trailing twelve months through Dec 2025 was $748.5 million (up 2.21% YoY), and the annual figure for FY2025 was $748.5 million, up 2.21%.
  • Other Non-Current Liabilities for Q4 2025 was $748.5 million at Biogen, down from $761.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for BIIB hit a ceiling of $1.4 billion in Q1 2021 and a floor of $556.7 million in Q2 2024.
  • Median Other Non-Current Liabilities over the past 5 years was $790.3 million (2023), compared with a mean of $955.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: plummeted 37.58% in 2023 and later surged 43.63% in 2025.
  • Biogen's Other Non-Current Liabilities stood at $1.3 billion in 2021, then decreased by 28.5% to $944.2 million in 2022, then dropped by 17.27% to $781.1 million in 2023, then fell by 6.25% to $732.3 million in 2024, then increased by 2.21% to $748.5 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $748.5 million (Q4 2025), $761.8 million (Q3 2025), and $799.6 million (Q2 2025) per Business Quant data.